We’re always told that drug prescribing is all about a careful balance between risk and benefit. People suffering from severe depression do need help, and occasionally a prescribed antidepressant can be helpful. But new research reveals that doctors...
Remicade was trumpeted as a wonder drug for rheumatoid arthritis and Crohn's disease when licensed for use six years ago.
HRT: Modesty forbids, but we told you so
The Pan European Trial in Adjuvant Colon Cancer-1 (PETACC-1) trial has been halted after preliminary results showed a high death rate from AstraZeneca's new drug, raltitrexed. ...
Methylphenidate (MPH) treatment 'may be associated with unacceptable side effects and risks' (J Clin Psychiatry, 1998; 59 [Suppl 7]: 42-9).
THALIDOMIDE: The Alien of the drug world
YOUR FRIENDLY DRUG DEALER: Yes, it’s the family GP
New research reveals that doctors need to think twice before prescribing antidepressants, and patients should think three times before taking them.
Another anti-inflammatory bites the dust. Another COX-2 inhibitor has been shot down by the FDA. Having spent the last two months reviewing the safety of the COX-2-selective non-steroidal anti-inflammatory drugs (NSAIDs), the US regulatory agency...
A drug for irritable bowel syndrome (IBS) which was linked to the deaths of at least five patients, within nine months of being licensed, may soon be back on the market.